Treatment with taxane agents (paclitaxel and docetaxel) for small cell lung cancer
HAYES, Inc.
Record ID 32006001008
English
Authors' objectives:
There are two approved drugs in the category known as the taxanes: paclitaxel and docetaxel. These drugs are administered as single agents, in combination with other chemotherapeutic agents and/or hematopoietic growth factors, or in combination with other modalities, such as radiotherapy, to attempt tumor shrinkage or remission and increase survival time and survival rate in patients with small cell lung cancer (SCLC).
Authors' methods:
Review
Details
Project Status:
Completed
Year Published:
2006
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=2133
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Carcinoma, Small Cell
- Paclitaxel
- Taxoids
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
HAYES, Inc.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.